Leverage the power of Placebell©™
The only placebo effect quantification tool to optimize clinical trial success.
Not managing the placebo response puts your clinical trials at risk –
a risk you can now avoid. Take action today.
Quantify the power of the mind.
To de-risk your phase ll and lll clinical trials starting today.
Every clinical trial patient is unique – and so is their placebo response. That’s why high failure rates in Phases II and III are still too common. How are you accounting for the placebo response in your clinical trials?
Placebell offers a sophisticated, yet simple, AI-based method to predict and account for individual patients’ placebo responsiveness in clinical trials. Deployed with only minimal changes to protocols and with no risk to your data analysis, Placebell helps sponsors bring life-saving therapies to market safely and efficiently.
0%Increase in study power
0%Decrease in variability
0%Decrease in sample size
Placebell has been deployed in more than a dozen studies across multiple indications.
Placebell poses no mathematical or operational negative impact on the trial or data.
Placebell uses advanced AI and machine learning to reduce variability in efficacy evaluation.
Step 1 Assess patient pyschological profile
Patients are administered a validated questionnaire only once in a trial. This measures personality traits, expectations and other factors.
Step 2 Calculate placebo response through our AI-powered platform
The Placebell©TM Covariate – defining each patient’s relative placebo responsiveness – is calculated using a machine learning-based model.
Step 3 Define and use covariates to de-risk trials
The Placebell©TM Covariate can then be used in statistical analysis to decrease variance and increase study power.
Disease areas where Placebell can help you achieve better phase 2 and 3 results.
And many more